ConAgra Foods said it would exit its struggling private label foods business and reported a 3.7 percent rise in quarterly sales.» Read More
International Paper on Wednesday reported fourth-quarter earnings of $134 million.
Hess Corp. on Wednesday reported a fourth-quarter loss of $8 million, after reporting a profit in the same period a year earlier.
General Dynamics reported a 42 percent jump in profit and said quarterly aircraft orders were at their highest in more than three years.
Japan's Canon reported a slight rise in profit thanks to a weaker yen, even as its camera business struggled to attract photographers.
Nintendo issued a profit warning, even as it sells fewer consoles, the sharp weakening of the yen means overseas sales will inflate its net income.
AmerisourceBergen on Wednesday reported a fiscal first-quarter loss of $199.9 million, after reporting a profit in the same period a year earlier.
American Electric Power on Wednesday reported fourth-quarter profit of $191 million, falling short of estimates.
Hennes & Mauritz posted fiscal fourth-quarter pretax profits slightly below market expectations Wednesday.
The head of Nordea bank, which hiked its dividend Wednesday on the back of solid earnings, said the Nordic lender had nothing to fear from Russia.
The company blew past even the most optimistic of Wall Street estimates for both revenue and earnings.
Yahoo's remaining 384 million shares of Alibaba, valued at $40 billion, will be wrapped into a newly formed independent entity, SpinCo.
The telecom giant posted fourth-quarter earnings of 55 cents per share, up from 53 cents a share in the year-earlier period.
Caterpillar Chairman and CEO Doug Oberhelman tells CNBC he's looking for a soft year 2015.
Pfizer reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased.
Procter & Gamble CFO Jon Moeller tells CNBC currency fluctuations were the prime headwind on disappointing earnings in the latest quarter.
DuPont says portfolio changes and productivity improvements contributed to an increase in fourth-quarter earnings.
United Technologies cut its full-year outlook because of the negative impact of a stronger dollar as the U.S. conglomerate reported higher earnings.
Novartis forecast sales and profits to grow at a faster pace this year driven by recent drug successes and its portfolio overhaul.
Siemens CEO has defended the company's decision to enter the U.S. shale space last year, as the group reported a steep drop in profit.
Bristol-Myers Squibb reported higher-than-expected earnings, helped by strong sales of its hepatitis C drugs and its Eliquis blood clot preventer.